FDA approves Boston Sci's MRI-compatible Precision Montage SCS System

• The FDA approves Boston Scientific's (BSX -0.5%) Precision Montage MRI Spinal Cord Stimulator System for the relief of chronic pain. The company plans to introduce the device at the 8th World Congress of the World Institute of Pain in New York, May 20-23.
• The product enables patients to undergo a full-body MRI while still benefiting from the pain relief of Precision Montage's MultiWave Technology, based on its proprietary Illumina 3D neural targeting algorithm, a computer model designed to assist doctors with point-and-click targeting in treating pain.